Acelrx pharmaceuticals to participate in the h.c. wainwright annual investment conference

Hayward, calif., sept. 6, 2022 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), ("acelrx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that chief executive officer, vince angotti will present in-person and be available for one-on-one meetings throughout the h.c.
ACRX Ratings Summary
ACRX Quant Ranking